Analyte Monitoring Device and Methods of Use

Abstract

An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

1 - 120 . (canceled) 
     
     
         121 . A system for providing glycemic control, comprising:
 a drug administration system;   an analyte sensor; and   a receiver that receives analyte level information from the analyte sensor,   wherein the drug administration system dispenses a drug based on the level of the analyte.   
     
     
         122 . A system for providing glycemic control, comprising:
 a drug administration system;   an analyte sensor;   a receiver that receives analyte level information from the analyte sensor; and   a processing unit configured to analyze data and predict future analyte levels, and further configured to determine a drug administration protocol in response to the data,   wherein the processing unit directs dispensing of the drug.   
     
     
         123 . The system of  claim 122 , wherein the data comprises a response to a treatment. 
     
     
         124 . The system of  claim 123 , wherein the treatment is an administration of insulin.